A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction
About 30% of patients with diffuse large B-cell lymphoma (DLBCL) relapse or exhibit refractory disease (r/r DLBCL) after first-line immunochemotherapy. Bone marrow (BM) involvement confers a dismal prognosis at diagnosis, likely due to the interaction between neoplastic cells and a complex tumor mic...
Main Authors: | Jessica Ceccato, Maria Piazza, Marco Pizzi, Sabrina Manni, Francesco Piazza, Ilaria Caputo, Francesco Cinetto, Lorena Pisoni, Diletta Trojan, Riccardo Scarpa, Renato Zambello, Angelo Paolo Dei Tos, Livio Trentin, Gianpietro Semenzato, Fabrizio Vianello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.947823/full |
Similar Items
-
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
by: Renato Zambello, et al.
Published: (2020-03-01) -
P1251: BONE-BASED 3D SCAFFOLD AS AN IN-VITRO MODEL OF MICROENVIRONMENT-LYMPHOMA INTERACTION
by: J. Ceccato, et al.
Published: (2022-06-01) -
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
by: Sabrina Manni, et al.
Published: (2022-08-01) -
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
by: Zaira Spinello, et al.
Published: (2021-04-01) -
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
by: Anna Fregnani, et al.
Published: (2022-08-01)